Tsg101	O
is	O
upregulated	O
in	O
a	O
subset	O
of	O
invasive	B-Cancer
human	I-Cancer
breast	I-Cancer
cancers	I-Cancer
and	O
its	O
targeted	O
overexpression	O
in	O
transgenic	O
mice	O
reveals	O
weak	O
oncogenic	O
properties	O
for	O
mammary	B-Cancer
cancer	I-Cancer
initiation	O
.	O

Previous	O
studies	O
reported	O
that	O
the	O
Tumor	O
Susceptibility	O
Gene	O
101	O
(	O
TSG101	O
)	O
is	O
upregulated	O
in	O
selected	O
human	O
malignancies	B-Cancer
,	O
and	O
the	O
expression	O
of	O
exogenous	O
Tsg101	O
was	O
suggested	O
to	O
transform	O
immortalized	O
fibroblasts	B-Cell
in	O
culture	O
.	O

To	O
date	O
,	O
the	O
potential	O
oncogenic	O
properties	O
of	O
Tsg101	O
have	O
not	O
been	O
examined	O
in	O
vivo	O
owing	O
to	O
the	O
lack	O
of	O
appropriate	O
model	O
systems	O
.	O

In	O
this	O
study	O
,	O
we	O
show	O
that	O
Tsg101	O
is	O
highly	O
expressed	O
in	O
a	O
subset	O
of	O
invasive	B-Cancer
human	I-Cancer
breast	I-Cancer
cancers	I-Cancer
.	O

Based	O
on	O
this	O
observation	O
,	O
we	O
generated	O
the	O
first	O
transgenic	O
mouse	O
model	O
with	O
a	O
targeted	O
overexpression	O
of	O
Tsg101	O
in	O
the	O
developing	O
mammary	B-Organ
gland	I-Organ
to	O
test	O
whether	O
exogenous	O
Tsg101	O
is	O
capable	O
of	O
initiating	O
tumorigenesis	O
.	O

Normal	O
functionality	O
of	O
exogenous	O
Tsg101	O
was	O
tested	O
by	O
rescuing	O
the	O
survival	O
of	O
Tsg101	O
-	O
deficient	O
mammary	B-Cell
epithelial	I-Cell
cells	I-Cell
in	O
conditional	O
knockout	O
mice	O
.	O

The	O
overexpression	O
of	O
Tsg101	O
resulted	O
in	O
increased	O
phosphorylation	O
of	O
the	O
epidermal	O
growth	O
factor	O
receptor	O
and	O
downstream	O
activation	O
of	O
MAP	O
kinases	O
.	O

Despite	O
an	O
increase	O
in	O
the	O
activation	O
of	O
these	O
signal	O
transducers	O
,	O
the	O
mammary	B-Organ
gland	I-Organ
of	O
females	O
expressing	O
exogenous	O
Tsg101	O
developed	O
normally	O
throughout	O
the	O
reproductive	O
cycle	O
.	O

In	O
aging	O
females	O
,	O
the	O
overexpression	O
of	O
Tsg101	O
seemed	O
to	O
increase	O
the	O
susceptibility	O
of	O
mammary	B-Tissue
epithelia	I-Tissue
toward	O
malignant	O
transformation	O
.	O

However	O
,	O
owing	O
to	O
the	O
long	O
latency	O
of	O
tumor	B-Cancer
formation	O
and	O
the	O
sporadic	O
occurrence	O
of	O
bona	O
fide	O
mammary	B-Cancer
cancers	I-Cancer
,	O
we	O
conclude	O
that	O
the	O
Tsg101	O
protein	O
has	O
only	O
weak	O
oncogenic	O
properties	O
.	O

Instead	O
of	O
cancer	B-Cancer
initiation	O
,	O
it	O
is	O
therefore	O
likely	O
that	O
Tsg101	O
plays	O
a	O
more	O
predominant	O
role	O
in	O
the	O
progression	O
of	O
a	O
subset	O
of	O
spontaneously	O
arising	O
breast	B-Cancer
cancers	I-Cancer
.	O

